Related Experiment Video
Updated: Aug 10, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Myocarditis in juvenile rheumatoid arthritis
Insights
Juvenile rheumatoid arthritis (JRA) can cause myocarditis in children, leading to heart failure. Adrenocorticosteroid treatment is effective, but digoxin requires careful use due to toxicity risks.
Area of Science:
- Pediatric Rheumatology
- Pediatric Cardiology
- Cardiovascular Pathology
Background:
- Juvenile rheumatoid arthritis (JRA) is a chronic inflammatory condition affecting children.
- Myocarditis, inflammation of the heart muscle, can be a rare but serious complication of systemic autoimmune diseases.
- Understanding cardiac involvement in JRA is crucial for timely diagnosis and management.
Observation:
- Three pediatric cases of myocarditis associated with active, severe JRA are presented.
- Diagnosis was based on cardiomegaly and/or congestive heart failure without significant pericardial effusion or other causes.
- Autopsy revealed diffuse "dilated ventricle" cardiomyopathy in a patient treated with high-dose steroids.
Findings:
- Myocarditis occurred in the context of severe, active systemic juvenile rheumatoid arthritis.
- High-dose adrenocorticosteroid therapy demonstrated rapid efficacy in managing the acute cardiac phase.
- Digoxin use necessitated extreme caution due to a high incidence of glycoside toxicity in these patients.
Implications:
- This highlights the importance of cardiac monitoring in children with severe JRA.
- Adrenocorticosteroids are a key therapeutic option for JRA-associated myocarditis.
- Careful consideration of medication toxicity, such as with digoxin, is essential in managing pediatric autoimmune heart conditions.
Abstract:
Three children are described who have had myocarditis as part of juvenile rheumatoid arthritis (JRA). The diagnosis was established by the appearance of cardiomegaly or congestive heart failure or both in the absence of substantial pericardial effusion or extra cardiac cause. Myocarditis, in these cases, occurred on a background of severe, active systemic disease. No pathologic specimens from hearts of acute cases are available, but an autopsy specimen of one child who died after two months of treatment with high doses of steroids showed diffuse changes typical of the "dilated ventricle" type of cardiomyopathy. Treatment with high doses of adrenocorticosteroids has been rapidly successful in controlling the acute phase, while digoxin must be used with extreme care because of high incidence of toxicity to glycosides.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

